Login / Signup

Prussian blue-based theranostics for ameliorating acute kidney injury.

Dong-Yang ZhangHengke LiuKathy S ZhuTing HeMuhammad Rizwan YounisChen YangShan LeiJiayingzi WuJing LinJunle QuPeng Huang
Published in: Journal of nanobiotechnology (2021)
Our findings suggested ultrasmall PB NZs, as nanozyme theranostics, have great potential for AKI management.
Keyphrases
  • acute kidney injury
  • cardiac surgery
  • heavy metals
  • human health
  • climate change
  • light emitting